Fusion Antibodies PLC
(LSE:FAB)
£
0.10
-0.0025 (-2.33%)
Market Cap: 13.14 Mil
Enterprise Value: 13.28 Mil
PE Ratio: 0
PB Ratio: 17.50
GF Score: 26/100 Fusion Antibodies PLC Investor Presentation and Q&A Session Transcript
Dec 16, 2025 / 04:00PM GMT
Release Date Price:
£0.1625
(-7.14%)
Adrian Kinkaid
Fusion Antibodies PLC - Chief Executive Officer, Executive Director
Hello. My name is Adrian Kinkaid. I'm the CEO of Fusion Antibodies, and I'm in San Diego today to help with the launch of OptiMAL at the Antibody Engineering and Therapeutics show. So what I wanted to do was update our investors with the latest happenings, and so we thought we would try this webinar format.
So the presentation I'm going to give is just a short extract from Rick's presentation on the main conference. And I'll just talk you through some of the highlights. I won't be able to do the full scientific justice that Rick can do; we simply don't have the time. However, if there are questions that are arising, then there is a facility on the Investor Hub to ask those towards the end.
So for anybody who doesn't know,
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot